Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Lung Diseases D008171 37 associated lipids
Sarcoidosis D012507 13 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Colitis D003092 69 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Skerk V et al. Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. 2001 Drugs Exp Clin Res pmid:11822223
[Antibiotics in respiratory tract infections. Enormous differences in compliance]. 2001 MMW Fortschr Med pmid:11824169
[Chronic bronchitis. When to use antibiotics?]. 2001 MMW Fortschr Med pmid:11824170
Burton MJ et al. Azithromycin for the treatment and control of trachoma. 2002 Expert Opin Pharmacother pmid:11829725
Biswas S In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. 2001 Oct-Dec J Postgrad Med pmid:11832638
Gaylor AS and Reilly JC Therapy with macrolides in patients with cystic fibrosis. 2002 Pharmacotherapy pmid:11837560
Smith SR et al. A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. 2002 J. Clin. Periodontol. pmid:11846850
Calvo A et al. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae]. 2001 Rev Esp Quimioter pmid:11856980
Wu ML et al. Enterocolonic Mycobacterium avium-intracellulare. 2002 Arch. Pathol. Lab. Med. pmid:11860323
Duff P Antibiotic selection in obstetrics: making cost-effective choices. 2002 Clin Obstet Gynecol pmid:11862059
Wolter J et al. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. 2002 Thorax pmid:11867823
Zhou F et al. High accuracy mass measurement of peptides with internal calibration using a dual electrospray ionization sprayer system for protein identification. 2002 Rapid Commun. Mass Spectrom. pmid:11870887
Martinez SM et al. Azithromycin prophylaxis during a hospitalwide outbreak of a pertussis-like illness. 2001 Infect Control Hosp Epidemiol pmid:11876458
Muirhead GJ et al. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers. 2002 Br J Clin Pharmacol pmid:11879258
Parchure N et al. Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. 2002 Circulation pmid:11901039
SoRelle R Treatment with azithromycin improves endothelial function. 2002 Circulation pmid:11902195
Ohara T et al. [Protective effect of azithromycin against verotoxin]. 2002 Kansenshogaku Zasshi pmid:11905000
Salaria M and Singh M Atypical pneumonia in children. 2002 Indian Pediatr pmid:11910135
Desta Z et al. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin. 2002 J Clin Psychopharmacol pmid:11910261
Kacmar J et al. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. 2001 Infect Dis Obstet Gynecol pmid:11916175
Treadway G et al. The safety of azithromycin in the treatment of adults with community-acquired respiratory tract infections. 2002 Int. J. Antimicrob. Agents pmid:11932140
Nalbanski B and Nalbanski A [Treatment of Chlamydia trachomatis with azatril]. 2002 Akush Ginekol (Sofiia) pmid:11935692
Krumov G et al. [Treatment of chlamydial cervicitis with azatril]. 2002 Akush Ginekol (Sofiia) pmid:11935693
Amsden GW et al. A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers. 2002 J Clin Pharmacol pmid:11936570
Lacroix JS et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. 2002 Acta Otolaryngol. pmid:11936912
King A et al. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. 2002 Clin. Microbiol. Infect. pmid:11952721
Blandizzi C et al. Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. 2002 Antimicrob. Agents Chemother. pmid:11959610
Ghaffar F et al. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. 2002 Clin. Infect. Dis. pmid:11981724
Edelstein PH Predicting the emergence of antimicrobial resistance. 2002 Clin. Infect. Dis. pmid:11981741
Ekici A et al. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. 2002 J Asthma pmid:11990233
Mohler AM Treatment of streptococcal pharyngitis. 2002 Am Fam Physician pmid:11996411
Davis JL et al. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. 2002 J. Vet. Pharmacol. Ther. pmid:12000529
Champney WS and Miller M Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin. 2002 Curr. Microbiol. pmid:12000992
Mandell GL and Coleman EJ Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes. 2002 J. Infect. Dis. pmid:12001049
Kutlin A et al. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model. 2002 J. Antimicrob. Chemother. pmid:12003969
Jung R et al. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila. 2002 J. Antimicrob. Chemother. pmid:12003984
Rustomjee R et al. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. 2002 J. Antimicrob. Chemother. pmid:12003988
Voytilla KL et al. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery. 2002 Am J Health Syst Pharm pmid:12004465
[Unfortunately without effectiveness: chlamydia eradication after infarct]. 2002 MMW Fortschr Med pmid:12014269
Suriawinata A and Min AD A 33-year-old woman with jaundice after azithromycin use. 2002 Semin. Liver Dis. pmid:12016551
Valleala H et al. [The unknown SAPHO]. 2000 Duodecim pmid:12017613
Evans AT et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. 2002 Lancet pmid:12020525
Campos-Outcalt D et al. Use of directly observed azithromycin treatment for syphilis in a homeless woman. 2002 Sex Transm Dis pmid:12035029
Ortega E et al. In vitro and ex vivo effects of erythromycin A, azithromycin and josamycin on the splenic response to specific antigens and mitogens. 2002 J. Antimicrob. Chemother. pmid:12039899
Chokephaibulkit K et al. Intestinal parasitic infections among human immunodeficiency virus-infected and -uninfected children hospitalized with diarrhea in Bangkok, Thailand. 2001 Southeast Asian J. Trop. Med. Public Health pmid:12041552
Lisby JG et al. [Bacteremia and meningitis caused by Streptococcus pneumoniae during treatment with azithromycin]. 2002 Ugeskr. Laeg. pmid:12043408
Nishikawa T [Comment on the contribution by Weigl CB et al. "Papillomatosis confluens et reticularis"]. 2002 Hautarzt pmid:12063751
Batieha A et al. No advantage of treating acute respiratory tract infections with azithromycin in a placebo-controlled study. 2002 Scand. J. Infect. Dis. pmid:12064684
Carryn S et al. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. 2002 Antimicrob. Agents Chemother. pmid:12069960
Babl FE et al. Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. 2002 Antimicrob. Agents Chemother. pmid:12069974
Chimura T [Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field]. 2002 Jpn J Antibiot pmid:12071097
Cohen R et al. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. 2002 Pediatr. Infect. Dis. J. pmid:12075760
Schaad UB et al. Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis. 2002 Pediatr. Infect. Dis. J. pmid:12075761
Domeika M et al. Chlamydia trachomatis infections in eastern Europe: legal aspects, epidemiology, diagnosis, and treatment. 2002 Sex Transm Infect pmid:12081171
Patrick DM et al. Heterosexual outbreak of infectious syphilis: epidemiological and ethnographic analysis and implications for control. 2002 Sex Transm Infect pmid:12083438
Reshetniak VI et al. [Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxycillin]. 2002 Antibiot. Khimioter. pmid:12087718
Kays MB et al. Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation. 2002 Diagn. Microbiol. Infect. Dis. pmid:12088625
Breier AR et al. Microbiological assay for azithromycin in pharmaceutical formulations. 2002 J Pharm Biomed Anal pmid:12093530
Bosch-Driessen LH et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. 2002 Am. J. Ophthalmol. pmid:12095805
Butler T Reduction of MIC of azithromycin for Salmonella typhi and Staphylococcus aureus in broth exposed to previous growth of Salmonella typhi. 2002 J. Antimicrob. Chemother. pmid:12096025
White RL et al. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000. 2002 Diagn. Microbiol. Infect. Dis. pmid:12106954
Matute AJ et al. Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers. 2002 Eur. J. Clin. Microbiol. Infect. Dis. pmid:12111597
Williams ES and Miller JM Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session. 2002 J. Am. Coll. Cardiol. pmid:12113263
Ohrt C et al. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. 2002 Antimicrob. Agents Chemother. pmid:12121927
Gandhi R et al. Characterization of azithromycin hydrates. 2002 Eur J Pharm Sci pmid:12128172
Fulcher SF et al. Delayed-onset mycobacterial keratitis after LASIK. 2002 Cornea pmid:12131028
Infection fighters. MAC prevention takes a holiday. 2000 TreatmentUpdate pmid:12132450
House D et al. Cytokine release by lipopolysaccharide-stimulated whole blood from patients with typhoid fever. 2002 J. Infect. Dis. pmid:12134261
Wallace Jr RJ et al. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. 2002 J. Infect. Dis. pmid:12134265
Fry AM et al. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. 2002 Clin. Infect. Dis. pmid:12145722
Shelby-James TM et al. Impact of single dose azithromycin on group A streptococci in the upper respiratory tract and skin of Aboriginal children. 2002 Pediatr. Infect. Dis. J. pmid:12150171
Weiss LM Babesiosis in humans: a treatment review. 2002 Expert Opin Pharmacother pmid:12150690
Blondeau JM The evolution and role of macrolides in infectious diseases. 2002 Expert Opin Pharmacother pmid:12150692
Cheng H et al. Synthesis and SAR of azalide 3,6-ketal aromatic derivatives as potent Gram-positive and Gram-negative antibacterial agents. 2002 Bioorg. Med. Chem. Lett. pmid:12161150
Silva FM et al. Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. 2002 Jan-Feb Rev Hosp Clin Fac Med Sao Paulo pmid:12170343
Hook EW et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. 2002 Sex Transm Dis pmid:12172535
Kawashima M et al. Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. 2002 Lung pmid:12182159
Yee CL et al. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. 2002 Pediatr. Infect. Dis. J. pmid:12182376
Clark C et al. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. 2002 Antimicrob. Agents Chemother. pmid:12183253
Ng LK et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. 2002 Antimicrob. Agents Chemother. pmid:12183262
Prunier AL et al. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. 2002 Antimicrob. Agents Chemother. pmid:12183270
Gaynor BD et al. Rationale for mass antibiotic distribution for trachoma elimination. 2002 Int Ophthalmol Clin pmid:12189619
Maizumi N et al. Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts. 2002 J. Periodont. Res. pmid:12200967
Kopjar B Azithromycin is effective in patients with chronic bronchitis. 2002 J. Antimicrob. Chemother. pmid:12205072
Baschiera F et al. Improved tonsillar disposition of azithromycin following a 3-day oral treatment with 20 mg kg(-1) in paediatric patients. 2002 Pharmacol. Res. pmid:12208127
Culić O et al. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. 2002 Eur. J. Pharmacol. pmid:12208321
Stone AF et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). 2002 Circulation pmid:12208796
Sirois F [Delirium associated with azithromycin administration]. 2002 Can J Psychiatry pmid:12211892
Lau CY and Qureshi AK Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. 2002 Sex Transm Dis pmid:12218839
Sieper J and Braun J [Diagnosis and antibiotic treatment of reactive arthritis]. 2002 Dtsch. Med. Wochenschr. pmid:12226789
Fraser-Hurt N and Mabey D Trachoma. 2002 Clin Evid pmid:12230687
Kim MK et al. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model. 2002 Antimicrob. Agents Chemother. pmid:12234843
Milberg P et al. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes. 2002 J. Pharmacol. Exp. Ther. pmid:12235254
Frank E et al. A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. 2002 Clin Ther pmid:12240780
Rao RU et al. Brugia malayi: effects of antibacterial agents on larval viability and development in vitro. 2002 Exp. Parasitol. pmid:12243742
Adimora AA Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. 2002 Clin. Infect. Dis. pmid:12353204
Augenbraun MH Treatment of syphilis 2001: nonpregnant adults. 2002 Clin. Infect. Dis. pmid:12353205
Steinberg JM and Srugo I Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids. 2002 Arch Pediatr Adolesc Med pmid:12361458
Gomberg MA [Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa]. 2002 Antibiot. Khimioter. pmid:12365322
Hammerschlag MR Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. 2002 Circulation pmid:12370232